A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 367 participants.

Also called NCT06603571

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 367 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06603571
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Argentina (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06603571. Randomized; double masking; primary purpose treatment. Start 2024-09-20 (actual); primary completion 2026-07-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Condition
Obesity
Condition
Overweight
Intervention (Drug)
LY3841136
Intervention (Drug)
Tirzepatide
Intervention (Drug)
Placebo
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct06603571
Content hash
b683f3afa363d099e5ed7e2994c13740a829556c79903404da305c84246ec39c